Peronosclerospora heteropogoni
Peronosclerospora heteropogoni
Description
Peronosclerospora heteropogoni is a pathogenic oomycete responsible for a specific form of downy mildew. As an obligate parasite, it specializes in infecting plants within the Poaceae family. This pathogen is known for its ability to induce systemic infections, meaning the fungus colonizes the internal tissues of the host plant, resulting in significant physiological disturbances.
The primary host range includes various wild grasses, notably Heteropogon contortus. However, in an agricultural context, this pathogen poses a threat to economically important crops such as maize and sorghum. The fungus disrupts the plant's ability to transport water and nutrients, often leading to systemic chlorosis and severe stunting of the infected specimens.
Diagnostic symptoms typically manifest as chlorotic streaks on the leaves. Under conditions of high relative humidity, a dense, whitish fungal growth consisting of conidiophores and conidia becomes visible on the underside of the leaves. Infected plants may exhibit stunted growth, excessive tillering, or failure to produce healthy inflorescences, depending on the severity of the infection.
The development and spread of Peronosclerospora heteropogoni are heavily dependent on environmental conditions. High humidity levels, coupled with temperatures between 18°C and 25°C, create an ideal environment for sporulation. The pathogen spreads primarily through windborne conidia and can persist in crop residues or soil, making it a challenging disease to manage in continuous cropping systems.
Economic damage caused by this pathogen is significant due to reduced biomass and impaired grain development. Integrated Pest Management (IPM) is essential for control. Strategies include the use of disease-free certified seeds, crop rotation to break the pathogen's life cycle, and the removal of infected plant debris. Chemical control is limited but may include systemic seed treatments to prevent early-stage infection and systemic disease progression.
Products · 0
Discussion
No discussions yet — be the first.